Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

cted GAAP Basic Income (Loss) per Common Share

to Basic Adjusted Income Per Common Share Guidance

(Unaudited)

Twelve Months Twelve Months

Ended Ended

December 31, 2007 December 31, 2008

Projected GAAP basic income (loss) per

common share $(3.08)-- $(2.98) $4.13 -- $4.23

Amortization of current intangibles $1.35 -- $1.35 $1.52 -- $1.52

Research and development adjustments $0.62 -- $0.62 $- -- $-

Settlement reserve $6.38 -- $6.38 $- -- $-

Gain on extinguishment of debt $(0.08)-- $(0.08) $- -- $-

Gain on sale of investment $(0.09)-- $(0.09) $- -- $-

Tax effect of pre-tax adjustments at

the applicable tax rates * $(0.65)-- $(0.65) $(0.55)--$(0.55)

Basic adjusted income per common share

guidance $4.45 -- $4.55 $5.10 -- $5.20

* For the twelve months ended December 31, 2007, we have not yet recognized a tax benefit for the settlement reserve due to the uncertainty associated with the tax treatment of any potential settlement.

The company's 2007 guidance is being issued based on certain assumptions including:

-- Adjusted effective tax rate of approximately 36 to 37 percent; and

-- Weighted average number of common shares outstanding of 66.6 million

shares for the twelve months ended December 31, 2007.

The company's 2008 guidance is being issued based on certain assumptions including:

-- Entrance into the market of an additional generic version of ACTIQ by

mid-2008;

-- Approval of TREANDA and mid-2008 launch;

-- Reduction of interest income by $20 million resulting from
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 15, 2014 Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology,  ... and collaborators of its exVive3D TM Human ... available in full commercial release on November 18, ... resulting in several awards for innovation. ...
(Date:12/13/2014)... , Dec. 12, 2014 /CNW/ - MaRS and Virgin Unite ... that they have joined forces to support Canadian entrepreneurs tackling ... Virgin Group Founder was at the MaRS Centre to announce ... national impact venture fund. This fund has $1 million in ... Vancouver -based Mindset Social Innovation Foundation, founded by ...
(Date:12/13/2014)... (PRWEB) December 13, 2014 According to ... million people between now and 2030." If a population ... the seventh most populous state in the country. , ... gathering at the Future of North Carolina Forum on ... Do we have the necessary infrastructure in place? Enough ...
(Date:12/13/2014)... SAN ANTONIO , Dec. 12, 2014 /PRNewswire/ ... presentation of data at the San Antonio Breast Cancer ... epoetin alfa plus best supportive care (BSC) versus BSC ... breast cancer receiving standard chemotherapy. This non-inferiority trial did ... out a 15 percent or greater increase in the ...
Breaking Biology Technology:Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 2Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 4Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 5Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 6Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 7Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 8Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 9Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 10Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 11Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 12
... YOKOHAMA, Japan, Aug. 27 MaxCyte,Inc. and ... the signing of an,exclusive license, development and ... system to support clinical studies and,commercialization of ... of the agreement, MaxCyte will provide the ...
... RESEARCH TRIANGLE PARK, N.C., Aug. 27 ... Pharmaceuticals, Inc., a,clinical-stage biopharmaceutical company specializing in ... private placement of C$26 million,(US$25 million) in ... investment by NovaQuest, the strategic partnering group,of ...
... Aug. 27 /Xinhua-PRNewswire-FirstCall/ -- China Technology,Development Group Corporation ... appointment of Charlene Hua as the Company,s new ... a board,resolution passed on the same date. This ... the Company. As Chief Financial Officer, Ms. ...
Cached Biology Technology:Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan 2Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan 3NovaQuest Advances 'Virtual Development' Model With Strategic Investment in TOPIGEN Pharmaceuticals 2China Technology Announces New Chief Financial Officer 2China Technology Announces New Chief Financial Officer 3
(Date:12/17/2014)...  HITLAB SM announced today its completion ... confirm its adherence to current U.S. Food and ... to conduct regulated smart device and smart phone ... safety and research quality. "HITLAB is ... delivery with innovative technology," said Laura Pugliese ...
(Date:12/17/2014)... Dec. 16, 2014  Automation is fundamentally transforming ... evident than at international borders. Over the past ... have allowed veteran travelers to self process through ... (APC) Kiosks at an increasing number of airports, ... According to Maxine Most , ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. ... the adoption of multimodal biometric systems. Multimodal biometric ... individual for verification and identification purposes. This helps ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Science Brief presents a roadmap for marine biodiversity science ... provides 95% of the habitable space on Earth and ... health of the oceans and their productive ecosystems which ... life is under significant threat from climate change and ...
... causing alarm among global public health authorities after it killed ... is now linked to two other cases of disease is ... found in bats, according to a genetic analysis to be ... the American Society for Microbiology, on November 20. Researchers studied ...
... including Carnegie Museum of Natural History scientist John ... Necrolestes patagonensis , whose name translates into grave ... This much-debated fossil mammal from South America has ... years. Scientific perseverance, a recent fossil discovery, and ...
Cached Biology News:Europe must not lose momentum in marine biodiversity research 2New coronavirus related to viruses from bats 2New coronavirus related to viruses from bats 3After 121 years, identification of 'grave robber' fossil solves a paleontological enigma 2After 121 years, identification of 'grave robber' fossil solves a paleontological enigma 3After 121 years, identification of 'grave robber' fossil solves a paleontological enigma 4After 121 years, identification of 'grave robber' fossil solves a paleontological enigma 5